1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Aquilo Capital Management, LLC Buys Blueprint Medicines Corp, Sells CytomX Therapeutics Inc, argenx SE, Loxo Oncology Inc

May 16, 2019 | About:

Investment company Aquilo Capital Management, LLC buys Blueprint Medicines Corp, sells CytomX Therapeutics Inc, argenx SE, Loxo Oncology Inc, Galapagos NV, MorphoSys AG during the 3-months ended 2019Q1, according to the most recent filings of the investment company, Aquilo Capital Management, LLC. As of 2019Q1, Aquilo Capital Management, LLC owns 13 stocks with a total value of $219 million. These are the details of the buys and sells.

For the details of Aquilo Capital Management, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/aquilo+capital+management%2C+llc/current-portfolio/portfolio

These are the top 5 holdings of Aquilo Capital Management, LLC
  1. iShares Nasdaq Biotechnology Index Fund (IBB) - 500,000 shares, 25.50% of the total portfolio.
  2. SPDR Series Trust S&P Biotech (XBI) - 500,000 shares, 20.65% of the total portfolio.
  3. Merus NV (MRUS) - 1,491,497 shares, 10.05% of the total portfolio. Shares added by 0.72%
  4. uniQure NV (QURE) - 364,596 shares, 9.92% of the total portfolio. Shares reduced by 10.8%
  5. Arrowhead Pharmaceuticals Inc (ARWR) - 982,455 shares, 8.23% of the total portfolio. Shares reduced by 7.74%
New Purchase: Blueprint Medicines Corp (BPMC)

Aquilo Capital Management, LLC initiated holding in Blueprint Medicines Corp. The purchase prices were between $48.7 and $86.6, with an estimated average price of $73.56. The stock is now traded at around $79.76. The impact to a portfolio due to this purchase was 1.12%. The holding were 30,618 shares as of .

Sold Out: argenx SE (ARGX)

Aquilo Capital Management, LLC sold out a holding in argenx SE. The sale prices were between $96.07 and $134.59, with an estimated average price of $117.13.

Sold Out: Loxo Oncology Inc (LOXO)

Aquilo Capital Management, LLC sold out a holding in Loxo Oncology Inc. The sale prices were between $131.02 and $234.75, with an estimated average price of $222.49.

Sold Out: MorphoSys AG (MOR)

Aquilo Capital Management, LLC sold out a holding in MorphoSys AG. The sale prices were between $22.55 and $29.84, with an estimated average price of $26.29.



Here is the complete portfolio of Aquilo Capital Management, LLC. Also check out:

1. Aquilo Capital Management, LLC's Undervalued Stocks
2. Aquilo Capital Management, LLC's Top Growth Companies, and
3. Aquilo Capital Management, LLC's High Yield stocks
4. Stocks that Aquilo Capital Management, LLC keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)